How do immune cells overcome the blood-brain barrier in multiple sclerosis?

Larochelle, Catherine, Alvarez, Jorge Ivan, Prat, Alexandre·2011·FEBS Letters

Cited by (404)

Items 101–200 of 404

  1. Internalization and presentation of myelin antigens by the brain endothelium guides antigen-specific T cell migration
    Melissa A Lopes Pinheiro, Alwin Kamermans, Juan Jesús García-Vallejo, Bert van het Hof, Laura Wierts, Tom G. O’Toole, Daniël Boeve, Marleen I. Verstege, Susanne M. A. van der Pol, Yvette van Kooyk et al. · 2016 · eLife
  2. Advancing neurological disorders therapies: Organic nanoparticles as a key to blood-brain barrier penetration
    Zahra Sadat Razavi, Seyed Sina Alizadeh, Fateme Sadat Razavi, Mohammad Souri, Madjid Soltani · 2025 · International Journal of Pharmaceutics
  3. Matrix metalloproteinases in the CNS: interferons get nervous
    Sameeksha Chopra, Christopher M. Overall, Antoine Dufour · 2019 · Cellular and Molecular Life Sciences
  4. Overcoming the Brain Barriers: From Immune Cells to Nanoparticles
    Marc Charabati, Jean‐Michel Rabanel, Charles Ramassamy, Alexandre Prat · 2019 · Trends in Pharmacological Sciences
  5. Impact of intestinal disorders on central and peripheral nervous system diseases
    Yumna El-Hakim, Shameena Bake, Kathiresh Kumar Mani, Farida Sohrabji · 2022 · Neurobiology of Disease
  6. Extracellular matrix metalloproteinase inducer shows active perivascular cuffs in multiple sclerosis
    Smriti M. Agrawal, Jacqueline Williamson, Ritu S. Sharma, Hania Kébir, Kamala D. Patel, Alexandre Prat, Voon Wee Yong · 2013 · Brain
  7. Dwellers and Trespassers: Mononuclear Phagocytes at the Borders of the Central Nervous System
    Daniela C. Ivan, Sabrina Walthert, Kristina Berve, Jasmin Steudler, Giuseppe Locatelli · 2021 · Frontiers in Immunology
  8. The nod-like receptor, Nlrp12, plays an anti-inflammatory role in experimental autoimmune encephalomyelitis
    Marjan Gharagozloo, Tara M Mahvelati, Emilie Imbeault, Pavel Gris, Echarki Zerif, Diwakar Bobbala, Subburaj Ilangumaran, Abdelaziz Amrani, Denis Gris · 2015 · Journal of Neuroinflammation
  9. Glial regulation of the blood-brain barrier in health and disease
    Bieke Broux, Elizabeth Gowing, Alexandre Prat · 2015 · Seminars in Immunopathology
  10. Angiopoietin-2 blockade ameliorates autoimmune neuroinflammation by inhibiting leukocyte recruitment into the CNS
    Li, Zhilin, Korhonen, Emilia A., Merlini, Arianna, Strauss, Judith, Wihuri, Eleonoora, Nurmi, Harri, Antila, Salli, Paech, Jennifer, Deutsch, Urban, Engelhardt, Britta et al. · 2020 · Journal of Clinical Investigation
  11. DICAM promotes T H 17 lymphocyte trafficking across the blood-brain barrier during autoimmune neuroinflammation
    Marc Charabati, Camille Grasmuck, Soufiane Ghannam, Lyne Bourbonnière, Antoine Philippe Fournier, Marc‐André Lécuyer, Olivier Tastet, Hania Kébir, Rose‐Marie Rébillard, Chloé Hoornaert et al. · 2022 · Science Translational Medicine
  12. Subtypes of schizophrenia identified by multi-omic measures associated with dysregulated immune function
    Chunyan Luo, Xuenan Pi, Na Hu, Xiao Wang, Yuan Xiao, Siyi Li, John A. Sweeney, Jeffrey R. Bishop, Qiyong Gong, Dan Xie et al. · 2021 · Molecular Psychiatry
  13. TREK-King the Blood–Brain-Barrier
    Stefan Bittner, Tobias Ruck, Juncal Fernández‐Orth, Sven Guenther Meuth · 2014 · Journal of Neuroimmune Pharmacology
  14. Neutrophil perversion in demyelinating autoimmune diseases: Mechanisms to medicine
    Courtney S. Casserly, Julia C. Nantes, Ryder Whittaker Hawkins, Luc Vallières · 2017 · Autoimmunity Reviews
  15. Blockade of MCAM/CD146 impedes CNS infiltration of T cells over the choroid plexus
    Johanna Breuer, Éva Korpos, Melanie‐Jane Hannocks, Tilman Schneider‐Hohendorf, Jian Song, Lisa Zondler, Sebastian Herich, Ken Flanagan, Thomas Korn, Alexander Zarbock et al. · 2018 · Journal of Neuroinflammation
  16. Drug discovery for remyelination and treatment of MS
    Katy LH Marshall-Phelps, Jason J. Early, David A. Lyons · 2017 · Glia
  17. Connexin Channels at the Glio-Vascular Interface: Gatekeepers of the Brain
    Marijke De Bock, Luc Leybaert, Christian Giaume · 2017 · Neurochemical Research
  18. Nanomaterials as Microglia Modulators in the Treatment of Central Nervous System Disorders
    Matteo Battaglini, Attilio Marino, Margherita Montorsi, Alessio Carmignani, Maria Cristina Ceccarelli, Gianni Ciofani · 2023 · Advanced Healthcare Materials
  19. Amelioration of Experimental autoimmune encephalomyelitis and DSS induced colitis by NTG-A-009 through the inhibition of Th1 and Th17 cells differentiation
    Suman Acharya, Maheshwor Timilshina, Liyuan Jiang, Sabita Neupane, Dong‐Young Choi, Sang‐Won Park, Sang Yeul Lee, Byeong‐Seon Jeong, Jung‐Ae Kim, Tae‐gyu Nam et al. · 2018 · Scientific Reports
  20. Remyelination in multiple sclerosis: Cellular mechanisms and novel therapeutic approaches
    John A. Olsen, Eitan M. Akirav · 2014 · Journal of Neuroscience Research
  21. Neuropilin-1 modulates interferon-γ-stimulated signaling in brain microvascular endothelial cells
    Ying Wang, Ying Cao, Ashutosh Kumar Mangalam, Yong Xia Guo, Reghann G. LaFrance‐Corey, Jeffrey D. Gamez, Pascal Aliihnui Atanga, Benjamin D. S. Clarkson, Yuebo Zhang, Enfeng Wang et al. · 2016 · Journal of Cell Science
  22. PARP inhibition in leukocytes diminishes inflammation via effects on integrins/cytoskeleton and protects the blood-brain barrier
    Slava Rom, Viviana Zuluaga‐Ramirez, Nancy Lee Reichenbach, Holly Dykstra, Sachin Gajghate, Pál Pacher, Yuri Persidsky · 2016 · Journal of Neuroinflammation
  23. Regulation of Human Brain Microvascular Endothelial Cell Adhesion and Barrier Functions by Memantine
    Fei Wang, Zhirong Zou, Yi Gong, Dong Yuan, Xun Chen, Tao Sun · 2017 · Journal of Molecular Neuroscience
  24. Viruses and Endogenous Retroviruses as Roots for Neuroinflammation and Neurodegenerative Diseases
    Christine Römer · 2021 · Frontiers in Neuroscience
  25. Pathogenic and physiological autoantibodies in the central nervous system
    Maike Gold, Refik Pul, Jan‐Philipp Bach, Martin Stangel, Richard C. Dodel · 2012 · Immunological Reviews
  26. Managing Multiple Sclerosis: Treatment Initiation, Modification, and Sequencing
    Mark Steven Freedman, Daniel H. Selchen, Alexandre Prat, Paul Steven Giacomini · 2018 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  27. MCAM+ brain endothelial cells contribute to neuroinflammation by recruiting pathogenic CD4+ T lymphocytes
    Marc Charabati, Stéphanie Zandee, Antoine Philippe Fournier, Olivier Tastet, Karine Thai, Roxaneh Zaminpeyma, Marc‐André Lécuyer, Lyne Bourbonnière, Sandra Larouche, Wendy Klément et al. · 2022 · Brain
  28. EGFL7 reduces CNS inflammation in mouse
    Catherine Larochelle, Timo Uphaus, Bieke Broux, Elizabeth Gowing, Magdalena Paterka, Laure Michel, Nevenka Dudvarski Stanković, Frank Bicker, Florent Lemaître, Alexandre Prat et al. · 2018 · Nature Communications
  29. Chronic systemic IL-1β exacerbates central neuroinflammation independently of the blood–brain barrier integrity
    Verónica Murta, María Isabel Farías, Fernando Juan Pitossi, Carina Cintia Ferrari · 2014 · Journal of Neuroimmunology
  30. Blood-brain barrier disturbances in diabetes-associated dementia: Therapeutic potential for cannabinoids
    Emily Brook, John C.L. Mamo, Rachel Heloise Xiwen Wong, Hani Al‐Salami, Marco Falasca, Virginie Lam, Ryusuke Takechi · 2019 · Pharmacological Research
  31. Targeting Phosphodiesterases—Towards a Tailor-Made Approach in Multiple Sclerosis Treatment
    Melissa Schepers, Assia Tiane, Dean Paes, Selien Sanchez, Ben Rombaut, Elisabeth Piccart, Bart P. F. Rutten, Bert Brône, Niels Hellings, Jos Prickaerts et al. · 2019 · Frontiers in Immunology
  32. Immune-mediated processes in neurodegeneration: where do we stand?
    Fakhoury, Marc · 2016 · Journal of Neurology
  33. Oncostatin M promotes excitotoxicity by inhibiting glutamate uptake in astrocytes: implications in HIV-associated neurotoxicity
    Shamsudheen Moidunny, Marco Matos, Evelyn M. Wesseling, Santanu Banerjee, David J. Volsky, Rodrigo Antunes Cunha, Paula M. Agostinho, H. W. G. M. Boddeke, Sabita Roy · 2016 · Journal of Neuroinflammation
  34. The role of oligodendrocytes and their progenitors on neural interface technology: A novel perspective on tissue regeneration and repair
    Steven M. Wellman, Franca Cambi, Takashi D.Y. Kozai · 2018 · Biomaterials
  35. Single-Cell Transcriptomics Identifies Brain Endothelium Inflammatory Networks in Experimental Autoimmune Encephalomyelitis
    Antoine Philippe Fournier, Olivier Tastet, Marc Charabati, Chloé Hoornaert, Lyne Bourbonnière, Wendy Klément, Sandra Larouche, Fiona Tea, Yu Chang Wang, Catherine Larochelle et al. · 2022 · Neurology Neuroimmunology & Neuroinflammation
  36. Evidence for Resident Memory T Cells in Rasmussen Encephalitis
    Geoffrey C. Owens, Julia W. Chang, My N. Huynh, Thabiso W. Chirwa, Harry V. Vinters, Gary W. Mathern · 2016 · Frontiers in Immunology
  37. Altered blood–brain barrier transport in neuro-inflammatory disorders
    Geert J. Schenk, Helga E. de Vries · 2016 · Drug Discovery Today Technologies
  38. Recent progress in blood-brain barrier transportation research
    Guangzhe Li, Kun Shao, Channakeshava Sokke Umeshappa · 2018 · Elsevier eBooks
  39. Pharmacological Inhibition of STAT3 by Stattic Ameliorates Clinical Symptoms and Reduces Autoinflammation in Myeloid, Lymphoid, and Neuronal Tissue Compartments in Relapsing–Remitting Model of Experimental Autoimmune Encephalomyelitis in SJL/J Mice
    Khalid Alhazzani, Sheikh F. Ahmad, Naif Obaid Al-Harbi, Sabry Mohamed Attia, Saleh A. Bakheet, Wedad S. Sarawi, Saleh Abdullah Alqarni, Mohammad Algahtani, Ahmed Nadeem · 2021 · Pharmaceutics
  40. Dysregulation of Endoplasmic Reticulum Stress and Autophagic Responses by the Antiretroviral Drug Efavirenz
    Luc Bertrand, Michal J. Toborek · 2015 · Molecular Pharmacology
  41. Endothelial-specific Crif1 deletion induces BBB maturation and disruption via the alteration of actin dynamics by impaired mitochondrial respiration
    Min Joung Lee, Yunseon Jang, Jeongsu Han, Soo J. Kim, Xianshu Ju, Yu Lim Lee, Jianchen Cui, Jiebo Zhu, Min Jeong Ryu, Song‐Yi Choi et al. · 2020 · Journal of Cerebral Blood Flow & Metabolism
  42. Encephalitogenic and Regulatory CD8 T Cells in Multiple Sclerosis and Its Animal Models
    Taryn E. Mockus, Ashley N Munie, Jeffrey Atkinson, Benjamin M. Segal · 2020 · The Journal of Immunology
  43. The effects of twenty-four nutrients and phytonutrients on immune system function and inflammation: a narrative review
    Jillian Poles, Elisa Karhu, Megan McGill, H. Reginald McDaniel, John Eugene Lewis · 2021 · Journal of Clinical and Translational Research
  44. Multiple Sclerosis and the Blood-Central Nervous System Barrier
    Alan M. Palmer · 2013 · Cardiovascular Psychiatry and Neurology
  45. ACKR1 favors transcellular over paracellular T‐cell diapedesis across the blood‐brain barrier in neuroinflammation in vitro
    Luca Marchetti, David Miguel Ferreira Francisco, Sasha GN Soldati, Neda Haghayegh Jahromi, Sara Barcos, Isabelle Gruber, Javier R. Pareja, Aude Thiriot, Ulrich H. von Andrian, Urban Deutsch et al. · 2021 · European Journal of Immunology
  46. Influence of Peripheral inflammation on the progression of multiple sclerosis: Evidence from the clinic and experimental animal models
    Verónica Murta, Carina Cintia Ferrari · 2012 · Molecular and Cellular Neuroscience
  47. A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis
    Smriti M Agrawal, Claudia Silva, Janet Wang, Jade Pui-Wai Tong, Voon Wee Yong · 2012 · Journal of Neuroinflammation
  48. Glycogen Synthase Kinase 3β Inhibition Prevents Monocyte Migration across Brain Endothelial Cells via Rac1-GTPase Suppression and Down-Regulation of Active Integrin Conformation
    Slava Rom, Shongshan Fan, Nancy Lee Reichenbach, Holly Dykstra, Servio H. Ramirez, Yuri Persidsky · 2012 · American Journal Of Pathology
  49. Neuroimmune connections between corticotropin-releasing hormone and mast cells: novel strategies for the treatment of neurodegenerative diseases
    Hongquan Dong, Yanning Qian, Piplu Bhuiyan, Yiwei Wang, Huan-Huan Sha · 2021 · Neural Regeneration Research
  50. IFP35 family proteins promote neuroinflammation and multiple sclerosis
    Xizhong Jing, Yongjie Yao, Danning Wu, Hao Hong, Xu Feng, Na Xu, Yingfang Liu, Huanhuan Liang · 2021 · Proceedings of the National Academy of Sciences
  51. miRNAs Participate in MS Pathological Processes and Its Therapeutic Response
    Ting Wu, Guangjie Chen · 2016 · Mediators of Inflammation
  52. Nanobiotechnology-based treatment strategies for malignant relapsed glioma
    Qiujun Qiu, Xinyi Ding, Jixiang Chen, Sunhui Chen, Jianxin Wang · 2023 · Journal of Controlled Release
  53. Cellular and Molecular Interactions in CNS Injury: The Role of Immune Cells and Inflammatory Responses in Damage and Repair
    Jai Chand Patel, Meenakshi Shukla, Manish Shukla · 2025 · Cells
  54. Cytokine Therapies in Neurological Disease
    Shila Azodi, Steven Jacobson · 2016 · Neurotherapeutics
  55. Regulatory role of oligodendrocyte gap junctions in inflammatory demyelination
    Christos P. Papaneophytou, Elena Georgiou, Christos Karaiskos, Irene Sargiannidou, Kyriaki Markoullis, Mona M. Freidin, Charles K. Abrams, Kleopas A. Kleopa · 2018 · Glia
  56. In Vivo PET Imaging of Adenosine 2A Receptors in Neuroinflammatory and Neurodegenerative Disease
    A. Vuorimaa, E. Rissanen, L. Airas · 2017 · Contrast Media & Molecular Imaging
  57. Novel pharmacological strategies to treat cognitive dysfunction in chronic obstructive pulmonary disease
    Aleksandar Dobric, Simone N. De Luca, Sarah J. Spencer, Steven Bozinovski, Michael M. Saling, Christine Faye McDonald, Ross Vlahos · 2021 · Pharmacology & Therapeutics
  58. A tissue chip with integrated digital immunosensors: In situ brain endothelial barrier cytokine secretion monitoring
    Shiuan‐Haur Su, Yujing Song, Andrew Stephens, Muyu Situ, Molly C. McCloskey, James L. McGrath, Anuska V. Andjelkovic, Benjamin H. Singer, Katsuo Kurabayashi · 2022 · Biosensors and Bioelectronics
  59. Stromal cell niches in the inflamed central nervous system.
    Pikor, Natalia B, Cupovic, Jovana, Onder, Lucas, Gommerman, Jennifer L, Ludewig, Burkhard · 2017 · The Journal of Immunology
  60. Absence of system xc − on immune cells invading the central nervous system alleviates experimental autoimmune encephalitis
    Ellen Merckx, Giulia Albertini, Magdalena Paterka, Cathy Jensen, Philipp Albrecht, Michael Dietrich, Joeri Van Liefferinge, Eduard Bentea, Lise Verbruggen, Thomas Demuyser et al. · 2017 · Journal of Neuroinflammation
  61. Emerging Role of ABC Transporters in Glia Cells in Health and Diseases of the Central Nervous System
    Maria Villa, Jingyun Wu, Stefanie Marie Hansen, Jens Pahnke · 2024 · Cells
  62. Sera from Remitting and Secondary Progressive Multiple Sclerosis Patients Disrupt the Blood-Brain Barrier
    Fumitaka Shimizu, Ayako Tasaki, Yasuteru Sano, Mihua Ju, Hideaki Nishihara, Mariko Oishi, Michiaki Koga, Motoharu Kawai, Takashi Kanda · 2014 · PLoS ONE
  63. Blood-Brain Barrier Permeability of Normal Appearing White Matter in Relapsing-Remitting Multiple Sclerosis
    Henrik Lund, Martin Krakauer, Arnold Skimminge, Finn Thorup Sellebjerg, Ellen Garde, Hartwig Roman Siebner, Olaf Bjarne Paulson, Dan Hesse, Lars G. Hanson · 2013 · PLoS ONE
  64. Experimental Models of Autoimmune Demyelinating Diseases in Nonhuman Primates
    Lev Stimmer, Claire-Maëlle Fovet, Ché Serguera · 2017 · Veterinary Pathology
  65. Ultrasound‐Sensitive Intelligent Nanosystems: A Promising Strategy for the Treatment of Neurological Diseases
    Xueting Pan, Wenping Huang, Guangjun Nie, Changyong Wang, Hai Wang · 2023 · Advanced Materials
  66. Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients
    Alessandro Trentini, Massimiliano Castellazzi, Carlo Cervellati, Maria Cristina Manfrinato, Carmine Tamborino, Stefania Hanau, Carlo Alberto Volta, Eleonora Baldi, Vladimir Kostić, Jelena S. Drulovic et al. · 2016 · Disease Markers
  67. Multiple sclerosis: Inflammation, autoimmunity and plasticity
    Mario Stampanoni Bassi, Ennio Iezzi, Diego Centonze · 2022 · Handbook of clinical neurology
  68. Role of sICAM-1 and sVCAM-1 as biomarkers in early and late stages of schizophrenia
    Maja Pantović-Stefanović, Nataša Petronijević, Bojana Dunjić-Kostić, Milica Velimirović, Tatjana Nikolić, Vladimir Jurišić, Maja Lačković, Aleksandar Damjanović, Sanja Totić-Poznanović, Aleksandar Jovanović et al. · 2015 · Journal of Psychiatric Research
  69. Precision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive Astrocytes
    Pekka Poutiainen, Merja Jaronen, Francisco Javier Quintana, Anna‐Liisa Brownell · 2016 · Frontiers in Molecular Neuroscience
  70. Identification of IL-17A-derived neural cell type and dynamic changes of IL-17A in serum/CSF of mice with ischemic stroke
    Shujuan Li, Qingqing Dai, Jinling Yu, Ting Liu, Shuiqiao Liu, Longhui Ma, Ying Zhang, Song Han, Junfa Li · 2017 · Neurological Research
  71. Single-cell profiling reveals GPCR heterogeneity and functional patterning during neuroinflammation
    Denise Tischner, Myriam Grimm, Harmandeep Kaur, Daniel Staudenraus, Jorge Carvalho, Mario Looso, Stefan Günther, Florian Wanke, Sonja Moos, Nelly Siller et al. · 2017 · JCI Insight
  72. Brown rats on farmland
    David Whyte Macdonald, Manuel Berdoy, Joanne P. Webster · 2015 · Oxford University Press eBooks
  73. The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases
    Arazu Sharif, John C.L. Mamo, Virginie Lam, Hani Al‐Salami, Armin Mooranian, Gerald Francis Watts, Roger Clarnette, Giuseppe Luna, Ryusuke Takechi · 2024 · Translational Neurodegeneration
  74. Overview of Experimental Models of the Blood‐Brain Barrier in CNS Drug Discovery
    Alan M. Palmer, Mohammad S. Alavijeh · 2013 · Current Protocols in Pharmacology
  75. RETRACTED ARTICLE: Protective Effect of a cAMP Analogue on Behavioral Deficits and Neuropathological Changes in Cuprizone Model of Demyelination
    Gelareh Vakilzadeh, Fariba Khodagholi, Tahereh Ghadiri, Marzieh Darvishi, Amir Ghaemi, Farshid Noorbakhsh, Ali Gorji, Mohammad Sharif Sharifzadeh · 2014 · Molecular Neurobiology · Retracted
  76. Lymphocyte-mediated neuroprotection in in vitro models of excitotoxicity involves astrocytic activation and the inhibition of MAP kinase signalling pathways
    Rajeev Shrestha, Owain R. Millington, James M. Brewer, Kumlesh Kumar Dev, Trevor John Bushell · 2013 · Neuropharmacology
  77. Concordant and Discordant Cerebrospinal Fluid and Plasma Cytokine and Chemokine Responses in Mild Cognitive Impairment and Early-Stage Alzheimer’s Disease
    Suzanne M. de la Monte, Ming Tong, Andrew J. Hapel · 2023 · Biomedicines
  78. Agent based modeling of the effects of potential treatments over the blood–brain barrier in multiple sclerosis
    Marzio Alfio Pennisi, Giulia Lo Russo, Santo Motta, Francesco Pappalardo · 2015 · Journal of Immunological Methods
  79. Neuregulin-1 beta 1 is implicated in pathogenesis of multiple sclerosis
    Hardeep Kataria, Christopher G Hart, Arsalan Alizadeh, Michael B. Cossoy, Deepak K Kaushik, Charles Noah Bernstein, Ruth Ann Marrie, Voon Wee Yong, Soheila Karimi‐Abdolrezaee · 2020 · Brain
  80. Wheel running reduces ethanol seeking by increasing neuronal activation and reducing oligodendroglial/neuroinflammatory factors in the medial prefrontal cortex
    Sucharita Sen Somkuwar, McKenzie J. Fannon, Atoosa Ghofranian, Jacqueline A. Quigley, Rahul R. Dutta, Melissa H. Galinato, Chitra D. Mandyam · 2016 · Brain Behavior and Immunity
  81. Peripheral Immune-Inflammatory Pathways in Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: Exploring Their Potential as Treatment Targets
    Abbas Firras Almulla, Michael H. J. Maes · 2025 · CNS Drugs
  82. Autoimmunity in multiple sclerosis: role of sphingolipids, invariant NKT cells and other immune elements in control of inflammation and neurodegeneration
    Maria Podbielska, Joan O’Keeffe, Edward L. Hogan · 2017 · Journal of the Neurological Sciences
  83. Evidence Implicating Blood-Brain Barrier Impairment in the Pathogenesis of Acquired Epilepsy following Acute Organophosphate Intoxication
    Pedro N. Bernardino, Audrey Luo, Peter M. Andrew, Chelsea M. Crowe, Marco I. González, Angie Gelli, Pamela J. Lein · 2023 · Journal of Pharmacology and Experimental Therapeutics
  84. Comparison of multiplex platforms for cytokine assessments and their potential use for biomarker profiling in multiple sclerosis
    Arjan Malekzadeh, Harry A. M. Twaalfhoven, Nienke J. Wijnstok, Joep Killestein, Marinus A. Blankenstein, Charlotte Elisabeth Teunissen · 2017 · Cytokine
  85. Antihypertensive agents do not prevent blood–brain barrier dysfunction and cognitive deficits in dietary-induced obese mice
    John C.L. Mamo, Virginie Lam, Corey Giles, Stephanie Coulson, Nicholas Fimognari, Armin Mooranian, Hani Al‐Salami, Ryusuke Takechi · 2017 · International Journal of Obesity
  86. Glatiramer Acetate Reverses Motor Dysfunction and the Decrease in Tyrosine Hydroxylase Levels in a Mouse Model of Parkinson's Disease
    Madeline J. Churchill, Mark A. Cantu, Ella Anle Kasanga, Cindy Moore, Michael F. Salvatore, Charles K. Meshul · 2019 · Neuroscience
  87. MRI monitoring of monocytes to detect immune stimulating treatment response in brain tumor
    Runze Yang, Susobhan Sarkar, Daniel J. Korchinski, Ying Wu, Voon Wee Yong, Jeff F. Dunn · 2016 · Neuro-Oncology
  88. Significance and Mechanisms of P-glycoprotein in Central Nervous System Diseases
    Liangliang Huang, Binbin Li, Xiang Li, Ge Liu, Rui Liu, Jia Guo, Baohui Xu, Yunman Li, Weirong Fang · 2019 · Current Drug Targets
  89. Contact-Dependent Granzyme B-Mediated Cytotoxicity of Th17-Polarized Cells Toward Human Oligodendrocytes
    Hélène Jamann, Qiao‐Ling Cui, Haritha L. Desu, Florian Pernin, Olivier Tastet, Alexandre Halaweh, Negar Farzam‐kia, Victoria Hannah Mamane, Oumarou Ouédraogo, Aurélie Cleret‐Buhot et al. · 2022 · Frontiers in Immunology
  90. A Microfluidic Human Model of Blood–Brain Barrier Employing Primary Human Astrocytes
    Eliana Lauranzano, Elena Campo, Marco Rasile, Raffaella Molteni, Marco Pizzocri, Lorena Passoni, Lorenzo Bello, Davide Pozzi, Ruggero Pardi, Michela Matteoli et al. · 2019 · Advanced Biosystems
  91. Unveiling the hidden connection: the blood-brain barrier’s role in epilepsy
    Jinkun Han, Ying Wang, Penghu Wei, Di Lu, Yongzhi Shan · 2024 · Frontiers in Neurology
  92. Mesenchymal stem cell-derived extracellular vesicles alleviate autism by regulating microglial glucose metabolism reprogramming and neuroinflammation through PD-1/PD-L1 interaction
    Qian Qin, Linlin Fan, Xin Zeng, Danyang Zheng, Han Wang, Mengyue Li, Yutong Jiang, Hui Wang, Hao Liu, Shengjun Liang et al. · 2025 · Journal of Nanobiotechnology
  93. Endothelial dysfunction in neurodegenerative disease: Is endothelial inflammation an overlooked druggable target?
    Megan Ritson, Caroline P.D. Wheeler-Jones, Helen B. Stolp · 2024 · Journal of Neuroimmunology
  94. Contributions of Drug Transporters to Blood-Brain Barriers
    Li Liu, Xiaodong Liu · 2019 · Advances in experimental medicine and biology
  95. Substances of abuse and the blood brain barrier: Interactions with physical exercise
    Marta A. Małkiewicz, Andrzej Małecki, Michal J. Toborek, Arkadiusz Szarmach, Paweł Jan Winklewski · 2020 · Neuroscience & Biobehavioral Reviews
  96. Cerebrovascular Reactivity and Neurovascular Coupling in Multiple Sclerosis—A Systematic Review
    M. Vestergaard, J. Frederiksen, H. Larsson, S. Cramer · 2022 · Frontiers in Neurology
  97. Cathelicidin‐related antimicrobial peptide promotes neuroinflammation through astrocyte–microglia communication in experimental autoimmune encephalomyelitis
    Anup Bhusal, Youngpyo Nam, Donggun Seo, Md Habibur Rahman, Eun Mi Hwang, Seung‐Chan Kim, Won‐Ha Lee, Kyoungho Suk · 2022 · Glia
  98. Computer design, synthesis, and bioactivity analyses of drugs like fingolimod used in the treatment of multiple sclerosis
    Gurbet Çelik Turgut, Doğukan Doyduk, Yılmaz Yıldırır, Serkan Yavuz, Atilla Akdemir, Ali Dişli, Alaattin Şen · 2016 · Bioorganic & Medicinal Chemistry
  99. Finding a Balance between Protection and Pathology: The Dual Role of Perforin in Human Disease
    Robin C. Orozco, Aaron J. Johnson · 2017 · International Journal of Molecular Sciences
  100. Clinical Relevance of BRAF V600E Mutation Status in Brain Tumors with a Focus on a Novel Management Algorithm
    Adam Kowalewski, Justyna Durślewicz, Marek Zdrenka, Dariusz Grzanka, Łukasz Szylberg · 2020 · Targeted Oncology